The Convergence of Microfluidics and Signal Inference
The next frontier in diagnostic medicine is not found in cloud-based deep learning, but in the physical orchestration of molecular signals at the point-of-care. In-situ proteomic signal decoupling represents a paradigm shift where physical fluidic channels act as the computational substrate, filtering high-noise biological samples before they ever reach a digital processor.
Underlying Architecture
By utilizing deterministic lateral displacement (DLD) arrays integrated with micro-scale resistive sensors, we can achieve 'analog pre-processing'. This architecture relies on the temporal separation of protein folding states based on hydrodynamic radius, effectively performing a physical Fourier transform on raw biological fluids. This reduces the feature-space dimensionality, allowing lightweight, embedded inference models to achieve high-fidelity classification of oncogenic biomarkers without the need for high-latency genomic sequencing.
- Real-time Processing: Removes the bottleneck of multi-hour lab-based proteomic assays.
- Noise Resilience: Physical separation of analytes inherently suppresses non-specific binding artifacts.
- Edge Inference: Low-power requirements enable integration into portable, handheld diagnostic devices.